Early-onset Alzheimer’s disease, also known as young-onset Alzheimer’s, refers to cases where symptoms begin before the age of 65. This form of Alzheimer’s is less common than the typical late-onset type but affects tens of thousands of people, many of…
Families considering lawsuits over forced COVID-19 vaccinations in nursing homes face a complex legal landscape shaped by public health policies, vaccine mandates, individual rights, and existing vaccine injury compensation programs. Whether families can sue depends on several factors including the…
The question of whether the FDA is too close to Big Pharma to effectively protect seniors with Alzheimer’s disease is complex and multifaceted. At its core, the concern revolves around the FDA’s role as a regulatory agency tasked with ensuring…
There is no credible evidence or official indication that former President Donald Trump plans to investigate the Centers for Disease Control and Prevention (CDC) specifically for mishandling dementia research. While Trump and his administration have been involved in controversies and…
Seniors are increasingly targeted by fake online cures claiming to treat or reverse Alzheimer’s disease, exploiting their vulnerability and desperation for hope. These scams often promise miraculous results with natural remedies or supplements that supposedly restore memory or cognitive function,…
Alzheimer’s research funding is facing significant challenges due to bureaucratic interference and mismanagement, which is causing delays and inefficiencies in the development of new treatments. There have been reports of critical review panels for Alzheimer’s clinical trials being canceled or…
Families of veterans may have legal grounds to sue over dementia cases linked to toxic exposure during military service, but such lawsuits are complex and depend on multiple factors including proof of exposure, causation, and applicable laws. Veterans themselves often…
The question of whether the U.S. Department of Health and Human Services (HHS) is protecting nursing homes instead of protecting families is complex and involves examining the roles, priorities, and outcomes of HHS policies and actions related to nursing homes…
Hospitals and nursing homes have increasingly faced legal scrutiny and lawsuits for over-prescribing antipsychotic medications to seniors, particularly those with dementia or other cognitive impairments. This issue has become a significant concern because antipsychotics, while sometimes used to manage behavioral…
Pharmaceutical executives involved in Alzheimer’s drug trials could potentially face criminal charges if investigations reveal misconduct such as fraud, misrepresentation, or deliberate deception in the conduct or reporting of clinical trials. This possibility arises amid growing scrutiny over the approval…